Literature DB >> 24121485

Glioblastoma stem cells are regulated by interleukin-8 signaling in a tumoral perivascular niche.

David W Infanger1, YouJin Cho, Brina S Lopez, Sunish Mohanan, S Chris Liu, Demirkan Gursel, John A Boockvar, Claudia Fischbach.   

Abstract

Glioblastoma multiforme contains a subpopulation of cancer stem-like cells (CSC) believed to underlie tumorigenesis and therapeutic resistance. Recent studies have localized CSCs in this disease adjacent to endothelial cells (EC) in what has been termed a perivascular niche, spurring investigation into the role of EC-CSC interactions in glioblastoma multiforme pathobiology. However, these studies have been limited by a lack of in vitro models of three-dimensional disease that can recapitulate the relevant conditions of the niche. In this study, we engineered a scaffold-based culture system enabling brain endothelial cells to form vascular networks. Using this system, we showed that vascular assembly induces CSC maintenance and growth in vitro and accelerates tumor growth in vivo through paracrine interleukin (IL)-8 signaling. Relative to conventional monolayers, endothelial cells cultured in this three-dimensional system not only secreted enhanced levels of IL-8 but also induced CSCs to upregulate the IL-8 cognate receptors CXCR1 and CXCR2, which collectively enhanced CSC migration, growth, and stemness properties. CXCR2 silencing in CSCs abolished the tumor-promoting effects of endothelial cells in vivo, confirming a critical role for this signaling pathway in GMB pathogenesis. Together, our results reveal synergistic interactions between endothelial cells and CSCs that promote the malignant properties of CSCs in an IL-8-dependent manner. Furthermore, our findings underscore the relevance of tissue-engineered cell culture platforms to fully analyze signaling mechanisms in the tumor microenvironment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24121485      PMCID: PMC3880850          DOI: 10.1158/0008-5472.CAN-13-1355

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  54 in total

Review 1.  Understanding the role of cytokines in Glioblastoma Multiforme pathogenesis.

Authors:  Vivian F Zhu; Jingxuan Yang; Drake G Lebrun; Min Li
Journal:  Cancer Lett       Date:  2011-11-07       Impact factor: 8.679

2.  EGFR signaling is differentially activated in patient-derived glioblastoma stem cells.

Authors:  Brian M Howard; Demirkan B Gursel; Anne-Marie Bleau; Robel T Beyene; Eric C Holland; John A Boockvar
Journal:  J Exp Ther Oncol       Date:  2010

3.  Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells.

Authors:  Lucia Ricci-Vitiani; Roberto Pallini; Mauro Biffoni; Matilde Todaro; Gloria Invernici; Tonia Cenci; Giulio Maira; Eugenio Agostino Parati; Giorgio Stassi; Luigi Maria Larocca; Ruggero De Maria
Journal:  Nature       Date:  2010-11-21       Impact factor: 49.962

Review 4.  Deadly teamwork: neural cancer stem cells and the tumor microenvironment.

Authors:  Justin D Lathia; John M Heddleston; Monica Venere; Jeremy N Rich
Journal:  Cell Stem Cell       Date:  2011-05-06       Impact factor: 24.633

5.  CD133(+) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling.

Authors:  Kwan Ho Tang; Stephanie Ma; Terence K Lee; Yuen Piu Chan; Pak Shing Kwan; Carol M Tong; Irene O Ng; Kwan Man; Ka-Fai To; Paul B Lai; Chung-Mau Lo; Xin-Yuan Guan; Kwok Wah Chan
Journal:  Hepatology       Date:  2012-01-13       Impact factor: 17.425

6.  Temozolomide-induced modification of the CXC chemokine network in experimental gliomas.

Authors:  Céline Bruyère; Tatjana Mijatovic; Caroline Lonez; Sabine Spiegl-Kreinecker; Walter Berger; Richard E Kast; Jean-Marie Ruysschaert; Robert Kiss; Florence Lefranc
Journal:  Int J Oncol       Date:  2011-03-08       Impact factor: 5.650

7.  Direct in vivo evidence for tumor propagation by glioblastoma cancer stem cells.

Authors:  Justin D Lathia; Joseph Gallagher; Jay T Myers; Meizhang Li; Amit Vasanji; Roger E McLendon; Anita B Hjelmeland; Alex Y Huang; Jeremy N Rich
Journal:  PLoS One       Date:  2011-09-22       Impact factor: 3.240

8.  Induction of immune mediators in glioma and prostate cancer cells by non-lethal photodynamic therapy.

Authors:  Robert Kammerer; Alexander Buchner; Patrick Palluch; Thomas Pongratz; Konstantin Oboukhovskij; Wolfgang Beyer; Ann Johansson; Herbert Stepp; Reinhold Baumgartner; Wolfgang Zimmermann
Journal:  PLoS One       Date:  2011-06-30       Impact factor: 3.240

9.  Involvement of metabotropic glutamate receptor 5, AKT/PI3K signaling and NF-κB pathway in methamphetamine-mediated increase in IL-6 and IL-8 expression in astrocytes.

Authors:  Ankit Shah; Peter S Silverstein; Dhirendra P Singh; Anil Kumar
Journal:  J Neuroinflammation       Date:  2012-03-15       Impact factor: 8.322

10.  Molecular genetic analysis of FGFR1 signalling reveals distinct roles of MAPK and PLCgamma1 activation for self-renewal of adult neural stem cells.

Authors:  Dengke K Ma; Karthikeyan Ponnusamy; Mi-Ryoung Song; Guo-li Ming; Hongjun Song
Journal:  Mol Brain       Date:  2009-06-08       Impact factor: 4.041

View more
  79 in total

1.  CEREBRAL ORGANOIDS AS A MODEL FOR GLIOBLASTOMA MULTIFORME.

Authors:  Nathaniel Silvia; Guohao Dai
Journal:  Curr Opin Biomed Eng       Date:  2020-03-25

2.  Cerebrospinal fluid and serum IL-8, CCL2, and ICAM-1 concentrations in astrocytic brain tumor patients.

Authors:  O M Koper; J Kamińska; K Sawicki; J Reszeć; R Rutkowski; M Jadeszko; Z Mariak; V Dymicka-Piekarska; H Kemona
Journal:  Ir J Med Sci       Date:  2017-10-30       Impact factor: 1.568

Review 3.  The Translational Significance of the Neurovascular Unit.

Authors:  Heather L McConnell; Cymon N Kersch; Randall L Woltjer; Edward A Neuwelt
Journal:  J Biol Chem       Date:  2016-12-05       Impact factor: 5.157

4.  IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells.

Authors:  Carolina Schinke; Orsolya Giricz; Weijuan Li; Aditi Shastri; Shanisha Gordon; Laura Barreyro; Laura Barreryo; Tushar Bhagat; Sanchari Bhattacharyya; Nandini Ramachandra; Matthias Bartenstein; Andrea Pellagatti; Jacqueline Boultwood; Amittha Wickrema; Yiting Yu; Britta Will; Sheng Wei; Ulrich Steidl; Amit Verma
Journal:  Blood       Date:  2015-03-25       Impact factor: 22.113

5.  A three-dimensional (3D) organotypic microfluidic model for glioma stem cells - Vascular interactions.

Authors:  Danh Truong; Roberto Fiorelli; Eric S Barrientos; Ernesto Luna Melendez; Nader Sanai; Shwetal Mehta; Mehdi Nikkhah
Journal:  Biomaterials       Date:  2018-07-30       Impact factor: 12.479

6.  Dissecting and rebuilding the glioblastoma microenvironment with engineered materials.

Authors:  Kayla J Wolf; Joseph Chen; Jason Coombes; Manish K Aghi; Sanjay Kumar
Journal:  Nat Rev Mater       Date:  2019-08-16       Impact factor: 66.308

7.  3D Mathematical Modeling of Glioblastoma Suggests That Transdifferentiated Vascular Endothelial Cells Mediate Resistance to Current Standard-of-Care Therapy.

Authors:  Huaming Yan; Mónica Romero-López; Lesly I Benitez; Kaijun Di; Hermann B Frieboes; Christopher C W Hughes; Daniela A Bota; John S Lowengrub
Journal:  Cancer Res       Date:  2017-05-23       Impact factor: 12.701

8.  Multidimensional hydrogel models reveal endothelial network angiocrine signals increase glioblastoma cell number, invasion, and temozolomide resistance.

Authors:  Mai T Ngo; Elijah Karvelis; Brendan A C Harley
Journal:  Integr Biol (Camb)       Date:  2020-06-19       Impact factor: 2.192

9.  Hydroxyapatite mineral enhances malignant potential in a tissue-engineered model of ductal carcinoma in situ (DCIS).

Authors:  Frank He; Nora L Springer; Matthew A Whitman; Siddharth P Pathi; Yeonkyung Lee; Sunish Mohanan; Stephen Marcott; Aaron E Chiou; Bryant S Blank; Neil Iyengar; Patrick G Morris; Maxine Jochelson; Clifford A Hudis; Pragya Shah; Jennie A M R Kunitake; Lara A Estroff; Jan Lammerding; Claudia Fischbach
Journal:  Biomaterials       Date:  2019-09-11       Impact factor: 12.479

Review 10.  Engineering strategies to mimic the glioblastoma microenvironment.

Authors:  Andrew Rape; Badriprasad Ananthanarayanan; Sanjay Kumar
Journal:  Adv Drug Deliv Rev       Date:  2014-08-29       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.